Therapeutics
Search By Attributes
Search Results
| Name | Synonyms | FDA Status | Company | Target Type | Therapy Type | Approved For |
|---|---|---|---|---|---|---|
| ACI-3024 | Tau MorphomerTM | Alzheimer's Disease (Inactive), Other Tauopathy (Phase 0) | AC Immune SA | Tau | Small Molecule | |
| ASN51 | ASN121151 | Alzheimer's Disease (Inactive) | Asceneuron SA | Tau | Small Molecule | |
| Davunetide | NAP, AL-108 |
Mild Cognitive Impairment (Inactive), Progressive Supranuclear Palsy (Inactive), Schizophrenia (Inactive), Frontotemporal Dementia (Inactive), Autism Spectrum Disorder (Phase 3) | Allon Therapeutics Inc., Exonavis Therapeutics Ltd., Paladin Labs Inc. | Tau | Other | |
| Lithium | lithium carbonate, lithium aspartate, lithium citrate, lithium orotate |
Alzheimer's Disease (Phase 4), Amyotrophic Lateral Sclerosis (Phase 3), Frontotemporal Dementia (Inactive), Mild Cognitive Impairment (Phase 4), Parkinson's Disease (Phase 2) | Amyloid-Related, Tau, Metals, Other | Other | Bipolar disorder | |
| PNT001 | Alzheimer's Disease (Inactive), Traumatic Brain Injury (Inactive) | Pinteon Therapeutics | Tau | Immunotherapy (passive) | ||
| Semorinemab | RO7105705 , MTAU9937A, RG6100 |
Alzheimer's Disease (Inactive) | AC Immune SA, Genentech, Hoffmann-La Roche | Tau | Immunotherapy (passive) | |
| TPI 287 | Alzheimer's Disease (Inactive), Corticobasal Degeneration (Inactive), Progressive Supranuclear Palsy (Phase 1) | Cortice Biosciences | Tau | Small Molecule |